Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma

Fountzilas, G; Tolis, C; Kalogera-Fountzila, A; Karanikiotis, C; Bai, M; Misailidou, D; Samantas, E; Athanassiou, E; Papamichael, D; Tsekeris, P; Catodritis, N; Nicolaou, A; Plataniotis, G; Makatsoris, T; Papakostas, P; Zamboglou, N; Daniilidis, J

dc.contributor.author	Fountzilas, G	en
dc.contributor.author	Tolis, C	en
dc.contributor.author	Kalogera-Fountzila, A	en
dc.contributor.author	Karanikiotis, C	en
dc.contributor.author	Bai, M	en
dc.contributor.author	Misailidou, D	en
dc.contributor.author	Samantas, E	en
dc.contributor.author	Athanassiou, E	en
dc.contributor.author	Papamichael, D	en
dc.contributor.author	Tsekeris, P	en
dc.contributor.author	Catodritis, N	en
dc.contributor.author	Nicolaou, A	en
dc.contributor.author	Plataniotis, G	en
dc.contributor.author	Makatsoris, T	en
dc.contributor.author	Papakostas, P	en
dc.contributor.author	Zamboglou, N	en
dc.contributor.author	Daniilidis, J	en
dc.date.accessioned	2014-03-01T01:22:31Z
dc.date.available	2014-03-01T01:22:31Z
dc.date.issued	2005	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/16598
dc.subject	Clinical Research	en
dc.subject	Epstein Barr Virus	en
dc.subject	Nasopharyngeal Carcinoma	en
dc.subject	Peripheral Blood	en
dc.subject	Polymerase Chain Reaction	en
dc.subject	Radiation Therapy	en
dc.subject	Side Effect	en
dc.subject	Complete Response	en
dc.subject	Detection Rate	en
dc.subject	To Treatment Failure	en
dc.title	Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma	en
heal.type	journalArticle	en
heal.identifier.primary	10.1007/s00066-005-1355-1	en
heal.identifier.secondary	http://dx.doi.org/10.1007/s00066-005-1355-1	en
heal.publicationDate	2005	en
heal.abstract	Background: Clinical research on the treatment of nasopharyngeal cancer (NPC) has been focused primarily on the reduction of incidence of the development of distant metastases as well as the improvement of locoregional control. Patients and Methods: Untreated patients with stage IIB–IVB nonmetastatic NPC were treated with three cycles of induction chemotherapy (IC) consisting of epirubicin 75 mg/m 2 followed by	en
heal.journalName	Strahlentherapie Und Onkologie	en
dc.identifier.doi	10.1007/s00066-005-1355-1	en